Safety and Adverse Events Related to COVID-19 mRNA Vaccines; a Systematic Review
Authors:
Open Access
- 1 January 2022
- journal article
- review article
- Published by Maad Rayan Publishing Company
- Vol. 10 (1) , e41
Abstract
Introduction: Knowledge of vaccine-related adverse events is crucial as they are among the most important factors that cause hesitation in receiving vaccines. Therefore, we aimed to systematically review the adverse events related to the mRNA vaccines reported in the literature. Methods: A systematic literature search was carried out in the databases of Scopus, PubMed, Cochrane, and Web of Science. We selected original studies that explored the side effects of mRNA COVID-19 vaccines using a two-phase (title/abstract and full-text) screening process. Results: Cardiac complications were the most commonly reported severe adverse events. It appeared that systemic adverse reactions are more common after the second dose of vaccines. The number of adverse effects reported after the Pfizer vaccine was higher than other vaccines, mostly due to its earlier approval and more widespread use throughout the world. Cardiac adverse events had a higher prevalence but no significant association has been found between COVID-19 mRNA vaccines and cardiac adverse events except for myopericarditis. Conclusion: Vaccines play a crucial role in controlling the COVID-19 pandemic and decreasing mortalities and the results of the present review acknowledge the fact that the benefits outweigh the adverse events of these vaccines.Keywords
This publication has 91 references indexed in Scilit:
- A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccineVaccine, 2021
- Adverse Events Reported From COVID-19 Vaccine Trials: A Systematic ReviewIndian Journal of Clinical Biochemistry, 2021
- Self-Reported Real-World Safety and Reactogenicity of COVID-19 Vaccines: A Vaccine Recipient SurveyLife, 2021
- Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021JAMA, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineNew England Journal of Medicine, 2021
- Reported orofacial adverse effects of COVID‐19 vaccines: The knowns and the unknownsJournal of Oral Pathology & Medicine, 2021
- One Year of COVID-19: The “New Normal”Indian Journal of Clinical Biochemistry, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine CandidatesNew England Journal of Medicine, 2020
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older AdultsNew England Journal of Medicine, 2020